Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025 Sep 17
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.